BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19133008)

  • 1. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Smolej L; Kasparová P
    APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Antic D; Jovanovic MP; Fekete MD; Cokic V
    Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):353-6. PubMed ID: 20182346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].
    Kasparová P; Smolej L
    Cesk Patol; 2007 Apr; 43(2):50-8. PubMed ID: 17623976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
    Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
    Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the role of angiogenesis and related factors in leukemias].
    Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
    Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
    Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Wozniak Z; Potoczek S; Ganczarski G; Wrobel T; Kuliczkowski K; Frydecka I; Jeleń M
    Anal Quant Cytol Histol; 2004 Oct; 26(5):263-70. PubMed ID: 15560532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
    Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
    Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
    Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
    Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE
    Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
    Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
    Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia].
    Zhang L; Wang HJ; Li HQ; Yang DL; Yan ZS; Wu YH; Zhou K; Chu YL; Chen HS; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):528-31. PubMed ID: 18078128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis is an independent prognostic factor in malignant mesothelioma.
    Edwards JG; Cox G; Andi A; Jones JL; Walker RA; Waller DA; O'Byrne KJ
    Br J Cancer; 2001 Sep; 85(6):863-8. PubMed ID: 11556838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.